| Date | Time | Source | Headline | Symbol | Company |
| 11/12/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris Announces Initiation of Phase 2 Portion of Phase 1/2 Trial with AEZS-108 in Prostate Cancer | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/12/2012 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris Announces Initiation of Phase 2 Portion of Phase 1/2 Trial with AEZS-108 in Prostate Cancer | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/12/2012 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris annonce le début de la portion phase 2 de l'étude de phase 1/2 sur AEZS-108 en cancer de la prostate | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/08/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris Presents Proof-of-Concept for Disorazol Z Cytotoxic Conjugates, such as AEZS-125, in Ovarian Cancer Mouse Mo... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/08/2012 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris Presents Proof-of-Concept for Disorazol Z Cytotoxic Conjugates, such as AEZS-125, in Ovarian Cancer Mouse Mo... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/08/2012 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris présente la validation de concept pour des conjugués cytotoxiques de disorazol Z, tel AEZS-125 en cancer d... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/07/2012 | 5:44PM | PR Newswire (US) | Top Six Stocks - Tuesday NASDAQ Volume Watch: Earthlink, Amyris, NII Holdings, Aeterna Zentaris, Affymetrix, ZaZa Energy | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/07/2012 | 5:44PM | PR Newswire (US) | Top Six Stocks - Tuesday NASDAQ Volume Watch: Earthlink, Amyris, NII Holdings, Aeterna Zentaris, Affymetrix, ZaZa Energy | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/07/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris to Announce Third Quarter 2012 Financial and Operating Results on November 13, 2012 | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/07/2012 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris to Announce Third Quarter 2012 Financial and Operating Results on November 13, 2012 | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/07/2012 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris dévoilera ses résultats financiers et d'exploitation du 3ième trimestre 2012 le 13 novembre 2012 | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/05/2012 | 3:14AM | Zacks | Zacks #1 Rank Additions for Monday - Tale of the Tape | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/01/2012 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris présentera la validation de concept pour des conjugués cytotoxiques de disorazol Z tel AEZS-125, en cancer... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/01/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris to Present Proof of Concept for Disorazol Z Cytotoxic Conjugates such as AEZS-125 in Ovarian Cancer Mouse Mo... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/01/2012 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris to Present Proof of Concept for Disorazol Z Cytotoxic Conjugates such as AEZS-125 in Ovarian Cancer Mouse Mo... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 11/01/2012 | 4:14AM | Zacks | Zacks #1 Rank Additions for Thursday - Tale of the Tape | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/22/2012 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/22/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/22/2012 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris redevient conforme au règlement sur le cours acheteur minimum d'un dollar du NASDAQ | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/19/2012 | 4:14AM | Zacks | Zacks #1 Rank Additions for Friday - Tale of the Tape | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/18/2012 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris : résultats de phase 3 pour AEZS-130 sur la déficience en hormone de croissance chez l'adulte présentés ... | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/18/2012 | 7:30AM | PR Newswire (US) | Aeterna Zentaris: Phase 3 Results for AEZS-130 in AGHD Presented at GRS and IGF Society Congress | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/18/2012 | 7:30AM | PR Newswire (Canada) | Aeterna Zentaris: Phase 3 Results for AEZS-130 in AGHD Presented at GRS and IGF Society Congress | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/17/2012 | 4:26PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/17/2012 | 9:24AM | PR Newswire (Canada) | Aeterna Zentaris annonce la clôture du placement public d'actions ordinaires et de bons de souscription de 16,5 M$ US | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/17/2012 | 9:23AM | PR Newswire (US) | Aeterna Zentaris Announces Closing of US$16.5 Million Public Offering of Common Shares and Warrants | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/17/2012 | 9:23AM | PR Newswire (Canada) | Aeterna Zentaris Announces Closing of US$16.5 Million Public Offering of Common Shares and Warrants | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/17/2012 | 9:00AM | Marketwired | Free Reports on AEterna Zentaris, Bankrate, Citigroup and YRC Worldwide Provided by the Bedford Report | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/17/2012 | 8:20AM | Marketwired | FDA Considering Faster Pathway for Treatments of Deadly or Debilitating Diseases | NASDAQ:AEZS | Aeterna Zentaris Inc |
| 10/16/2012 | 4:14AM | Zacks | Zacks #1 Rank Additions for Tuesday - Tale of the Tape | NASDAQ:AEZS | Aeterna Zentaris Inc |